发明名称 |
ORAL FORMULATIONS OF GLYCYL-2-METHYLPROLYL-GLUTAMATE |
摘要 |
Oral formulations of G-2MePE including microemulsions, coarse emulsions, liquid crystals, tablets and encapsulated forms of G-2MePE have improved bioavailability than conventional aqueous formulations. In particular, microparticles, nanoparticles and microemulsions can exhibit great neuroprotective effects after oral administration. In a microemulsion formulation, G-2MePE can nearly completely inhibit cerebral infarction in an animal model of stroke even after the stroke had been initiated. Thus, improved oral formulations can be desirably used to treat a variety of neurodegenerative conditions with improved convenience and improved efficacy. |
申请公布号 |
WO2007106555(A3) |
申请公布日期 |
2008.10.30 |
申请号 |
WO2007US06528 |
申请日期 |
2007.03.14 |
申请人 |
NEUREN PHARMACEUTICALS LIMITED;NEUREN PHARMACEUTICALS, INC.;WEN, JINGYUAN;THOMAS, GREGORY BRIAN;BICKERDIKE, MIKE JOHN |
发明人 |
WEN, JINGYUAN;THOMAS, GREGORY BRIAN;BICKERDIKE, MIKE JOHN |
分类号 |
A61F2/00 |
主分类号 |
A61F2/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|